30-day average of 13 articles · scale −100 to +100
Across 13 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of Axon Enterprise news is Somewhat Bullish (+34)
on a scale from −100 to +100.
That is up 16 points from the previous 30 days (+18).
💻 Software revenue grew 43% YoY to $437M, nearing half of total revenue.
📉 Stock fell 18.2% after Q3 report and $1.0B convertible note offering.
Somewhat Bearish -45
Why Did Axon Stock Fall?
AI-generated analysis
Key insights
📉 Axon stock fell 18.2% on November 6, 2026, following the release of its fiscal Q3 2026 report and a $1.0 billion convertible note offering.
💰 The company's balance sheet shifted from net cash to net debt, with total debt at $2,969 million versus $1,655 million in cash as of September 30, 2026.
📉 Management lowered its free cash flow guidance for 2026 to a range of $350-$400 million from a previous target of $450 million due to increased inventory investment.
🚁 Axon is investing $1.2 billion in Skydio, a drone maker, using a combination of cash and stock as part of its strategic expansion.
📅 Revenue recognition for three federal Dedrone deployments totaling approximately $130 million has been moved out of fiscal 2026.
💻 Software and Services revenue grew 43% year-over-year to $437 million in Q3, approaching half of the company's total revenue.
📈 Annual recurring revenue increased 40% to $1.8 billion, highlighting strong growth in the software segment.
📉 Operating margins were low at 2.0% over the trailing twelve months, significantly below the S&P 500 average of 19.0%.
📊 The stock trades at 96.3 times reported earnings and 7.3 times sales, reflecting a high valuation relative to current profitability.
⚡ Total revenue grew 33.6% year-over-year through September 2026, though TASER 7 sales declined modestly.
📈 Bullish signals
💻Software and Services revenue surged 43% year-over-year to $437 million in fiscal Q3 2026, approaching half of total revenue.
📈Annual recurring revenue grew 40% to $1.8 billion, demonstrating strong stickiness in the software business.
⚡Total revenue increased 33.6% year-over-year through September 2026, maintaining double-digit growth despite market headwinds.
📊The company maintains a high valuation multiple of 7.3 times sales and 96.3 times earnings, indicating strong investor confidence in future cash flows.
📉 Risk factors
📉Axon stock fell 49.9% between August and November 2026, with an 18.2% drop on the day of the Q3 report release.
📉Management lowered free cash flow guidance for 2026 to $350-$400 million from a prior target of $450 million.
💰The company's balance sheet flipped from net cash to net debt, with total debt at $2,969 million versus $1,655 million in cash.
📉Operating margins were weak at 2.0% over the trailing twelve months, compared to a 19.0% average for the S&P 500.
📅Revenue recognition for approximately $130 million of federal Dedrone deployments was moved out of fiscal 2026.
⚡TASER revenue declined modestly due to lower sales of the TASER 7 model.
Article
Axon Enterprise (AXON) shares experienced significant volatility, falling 49.9% between August and November 2026, with the steepest decline occurring after the release of its fiscal Q3 2026 report. The stock dropped 18.2% on November 6 following management's announcement that it would borrow $1.0 billion via convertible notes to fund strategic investments and inventory buildup. This capital raise marked a shift in the company's balance sheet, moving from a net cash position to one carrying more debt than cash.
Management revised its financial outlook for fiscal year 2026, guiding free cash flow between $350 million and $400 million, down from a prior target of $450 million. A substantial portion of the borrowed funds is allocated to a $1.2 billion investment in Skydio, a drone manufacturer, which will be paid for using a mix of cash and stock. Additionally, Axon adjusted its revenue recognition timing, moving drone revenue associated with three federal Dedrone deployments out of 2026, representing nearly 500 basis points of expected growth.
Despite the stock price decline, Axon's software business continues to expand rapidly, with Software and Services revenue rising 43% year-over-year to $437 million in Q3. However, the company faces valuation challenges, trading at 96.3 times reported earnings compared to 21.9 for the S&P 500, while operating margins remain low at 2.0% over the trailing twelve months versus 19.0% for the broader index.
Revenue growth remains robust overall, with total revenue increasing 33.6% year-over-year through September 2026, though TASER sales declined modestly due to lower demand for the TASER 7 model. Analysts and investors are closely watching the software segment's performance as a key indicator of future profitability, with fiscal Q4 2026 results expected in February 2027.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
Capital raisingCompany updateAI-generated analysis
Axon Enterprise (AXON) shares experienced significant volatility, falling 49.9% between August and November 2026, with the steepest decline occurring after the release of its fiscal Q3 2026 report. The stock dropped 18.2% on November 6 following management's announcement that it would borrow $1.0 billion via convertible notes to fund strategic investments and inventory buildup. This capital raise marked a shift in the company's balance sheet, moving from a net cash position to one carrying more debt than cash.
Management revised its financial outlook for fiscal year 2026, guiding free cash flow between $350 million and $400 million, down from a prior target of $450 million. A substantial portion of the borrowed funds is allocated to a $1.2 billion investment in Skydio, a drone manufacturer, which will be paid for using a mix of cash and stock. Additionally, Axon adjusted its revenue recognition timing, moving drone revenue associated with three federal Dedrone deployments out of 2026, representing nearly 500 basis points of expected growth.
Despite the stock price decline, Axon's software business continues to expand rapidly, with Software and Services revenue rising 43% year-over-year to $437 million in Q3. However, the company faces valuation challenges, trading at 96.3 times reported earnings compared to 21.9 for the S&P 500, while operating margins remain low at 2.0% over the trailing twelve months versus 19.0% for the broader index.
Revenue growth remains robust overall, with total revenue increasing 33.6% year-over-year through September 2026, though TASER sales declined modestly due to lower demand for the TASER 7 model. Analysts and investors are closely watching the software segment's performance as a key indicator of future profitability, with fiscal Q4 2026 results expected in February 2027.
📉 Stock fell 18.2% after Q3 report and $1.0B convertible note offering.
💰 Net cash shifted to net debt with $2,969M total debt vs $1,655M cash.
📉 FCF guidance lowered to $350-$400M due to increased inventory investment.
🚁 Investing $1.2B in Skydio drone maker for strategic expansion.
💻 Software revenue grew 43% YoY to $437M, nearing half of total revenue.
📉 Axon stock fell 18.2% on November 6, 2026, following the release of its fiscal Q3 2026 report and a $1.0 billion convertible note offering.
💰 The company's balance sheet shifted from net cash to net debt, with total debt at $2,969 million versus $1,655 million in cash as of September 30, 2026.
📉 Management lowered its free cash flow guidance for 2026 to a range of $350-$400 million from a previous target of $450 million due to increased inventory investment.
🚁 Axon is investing $1.2 billion in Skydio, a drone maker, using a combination of cash and stock as part of its strategic expansion.
📅 Revenue recognition for three federal Dedrone deployments totaling approximately $130 million has been moved out of fiscal 2026.
💻 Software and Services revenue grew 43% year-over-year to $437 million in Q3, approaching half of the company's total revenue.
📈 Annual recurring revenue increased 40% to $1.8 billion, highlighting strong growth in the software segment.
📉 Operating margins were low at 2.0% over the trailing twelve months, significantly below the S&P 500 average of 19.0%.
📊 The stock trades at 96.3 times reported earnings and 7.3 times sales, reflecting a high valuation relative to current profitability.
⚡ Total revenue grew 33.6% year-over-year through September 2026, though TASER 7 sales declined modestly.
Bullish Signals
Software revenue surged 43% YoY to $437M in Q3 2026.
Annual recurring revenue grew 40% to $1.8B.
Total revenue rose 33.6% YoY through September 2026.
Valuation multiples of 7.3x sales and 96.3x earnings.
Risk Factors
Stock fell 49.9% between August and November 2026.
Management lowered free cash flow guidance for 2026.
Balance sheet flipped from net cash to net debt.
Operating margins were weak at 2.0% over trailing twelve months.
Revenue recognition for $130 million of federal Dedrone deployments moved out.
Bullish Signals
Software and Services revenue surged 43% year-over-year to $437 million in fiscal Q3 2026, approaching half of total revenue.
Annual recurring revenue grew 40% to $1.8 billion, demonstrating strong stickiness in the software business.
Total revenue increased 33.6% year-over-year through September 2026, maintaining double-digit growth despite market headwinds.
The company maintains a high valuation multiple of 7.3 times sales and 96.3 times earnings, indicating strong investor confidence in future cash flows.
Risk Factors
Axon stock fell 49.9% between August and November 2026, with an 18.2% drop on the day of the Q3 report release.
Management lowered free cash flow guidance for 2026 to $350-$400 million from a prior target of $450 million.
The company's balance sheet flipped from net cash to net debt, with total debt at $2,969 million versus $1,655 million in cash.
Operating margins were weak at 2.0% over the trailing twelve months, compared to a 19.0% average for the S&P 500.
Revenue recognition for approximately $130 million of federal Dedrone deployments was moved out of fiscal 2026.
TASER revenue declined modestly due to lower sales of the TASER 7 model.
Carillon Tower Advisers released its Q3 2026 investor letter, noting that Axon Enterprise, Inc. (NASDAQ:AXON) detracted from the performance of its Carillon Eagle Mid Cap Growth Fund. The fund manager highlighted that while the broader mid-cap growth sector faced headwinds from energy inflation and AI fatigue, Axon specifically suffered a 25.92% stock decline over the past month, resulting in a 52-week loss of 46.88%. Despite these market pressures, the company closed at $302.54 per share with a market capitalization of $24.64 billion.
The letter details that Axon delivered another strong quarter characterized by robust revenue growth, accelerating recurring revenue, and increased full-year revenue guidance. However, the stock faced significant pressure due to near-term gross margin pressure caused by investments in scaling newer products and professional services. Additionally, a convertible debt offering raised investor concerns regarding potential cash generation issues and equity dilution.
Despite these financial headwinds, the article emphasizes that underlying demand for Axon's public safety technology remains particularly strong. The company continues to see adoption of its expanding ecosystem, which includes TASER devices, body cameras, digital evidence management software, and AI-enabled solutions. The fund manager concludes that while near-term concerns exist regarding margins and capital structure, the fundamental demand supports the business.
📉 Stock dropped 25.92% monthly amid 46.88% 52-week loss per Carillon Tower Advisers.
💰 Closed at $302.54 with $24.64B market cap, hurting Carillon Eagle Mid Cap Growth Fund.
⚠️ Near-term gross margin pressure stems from scaling new products and professional services.
💸 Convertible debt offering raised concerns over cash generation and equity dilution risks.
📉 Axon Enterprise stock declined 25.92% over the past month, contributing to a 52-week loss of 46.88% as noted in Carillon Tower Advisers' Q3 2026 investor letter.
💰 The company closed at $302.54 per share with a market capitalization of $24.64 billion, though it detracted from the performance of the Carillon Eagle Mid Cap Growth Fund.
📈 Axon reported another strong quarter featuring robust revenue growth, accelerating recurring revenue, and an increase in full-year revenue guidance.
⚠️ Near-term gross margin pressure is impacting the stock due to investments in scaling newer products and professional services.
💸 A convertible debt offering raised investor concerns regarding potential cash generation challenges and equity dilution risks.
🛡️ Underlying demand remains strong, supported by continued adoption of Axon's expanding ecosystem including TASER devices, body cameras, and AI-enabled solutions.
Bullish Signals
Revenue grew strongly with accelerating recurring revenue.
Company updateEarnings reportGuidance loweredAI-generated analysis
Axon Enterprise (AXON) reported its Q3 2026 results, revealing a sharp divergence between strong top-line growth and deteriorating cash flow expectations. While revenue surged to approximately US$909 million, representing a 28% year-over-year increase driven by a shift toward premium software bundles, the stock price fell 18.2% to close around US$313. This decline reflects investor concern over a significant reset in free cash flow guidance and margin pressures associated with the company's hardware-heavy public safety platform.
The core of the earnings story highlights Axon's successful transition toward recurring revenue, with Annual Recurring Revenue (ARR) growing 39% annually to US$1.6 billion and net revenue retention standing at a robust 126%. However, these software-centric gains are currently being offset by hardware-specific headwinds. Rising memory costs for cameras and the introduction of new counter-drone hardware are dragging down connected device margins, with analysts expecting these pressures to weigh on adjusted EBITDA in the near term.
Despite the short-term cash strain, Axon maintains a strong long-term outlook supported by substantial future contracted bookings of US$15.1 billion and a growing software segment that now accounts for nearly half of total revenue. The company's adjusted gross margin remains healthy at 59.2%, though inventory builds of roughly US$100 million are necessary to support future deployments, temporarily squeezing free cash flow which is now guided between US$350 million and US$400 million.
📉 Stock dropped 18.2% after free cash flow guidance reset to $350M-$400M.
💰 Revenue rose 28% to $908.6M driven by premium plan adoption.
📈 Returned to profitability with $57M net income vs $2.2M loss last year.
💻 Software revenue hit $437M, nearing 50% of total as margins improve.
⚠️ Inventory up $100M and memory costs squeeze near-term cash flow.
📉 Axon Enterprise stock price dropped 18.2% to approximately US$313 following the Q3 2026 earnings release due to a sharp reset in free cash flow guidance.
💰 Revenue reached US$908.6 million, marking a 28% increase compared to the prior year quarter driven by premium plan adoption.
📈 The company returned to profitability with net income of US$57.0 million, reversing a loss of US$2.2 million in the same period last year.
💻 Software & Services revenue hit US$437 million, nearing 50% of total revenue as the business shifts toward high-margin recurring models.
🔄 Annual Recurring Revenue grew 39% to US$1.6 billion with a net revenue retention rate of 126%, indicating strong customer stickiness.
⚠️ Adjusted gross margin sits at 59.2% but faces headwinds from rising memory costs for cameras and new counter-drone hardware margins.
📦 Inventory levels increased by approximately US$100 million to support future deployments, contributing to the near-term cash flow squeeze.
🔮 Future contracted bookings stand at a record US$15.1 billion, providing a sturdy foundation for long-term recurring revenue growth.
💸 Free cash flow guidance was reset to a range of US$350 million to US$400 million for the current fiscal year.
📉 Adjusted EBITDA margin is near 26%, though memory inflation and hardware mix shifts are expected to weigh on this metric in Q4 and beyond.
Bullish Signals
Revenue surged 28% YoY to US$908.6M.
Transitioned to profitability with US$57.0M net income.
ARR grew 39% to US$1.6B with 126% retention.
Software revenue hit US$437M, nearing half of total.
Future bookings reached record US$15.1B.
Risk Factors
FCF guidance reset to $350M-$400M due to $100M inventory builds.
Rising memory costs drag down connected device profitability.
EBITDA margins face inflation pressure through 2028.
Bullish Signals
Revenue surged 28% year-over-year to US$908.6 million, demonstrating strong demand for the company's public safety platform.
The business successfully transitioned to profitability with net income of US$57.0 million, reversing a loss from the prior year period.
Annual Recurring Revenue grew 39% annually to US$1.6 billion, supported by a high net revenue retention rate of 126%.
The software segment is rapidly scaling, with Software & Services revenue reaching US$437 million and approaching half of total revenue.
Future contracted bookings reached a record US$15.1 billion, signaling strong visibility into long-term recurring revenue streams.
Risk Factors
Free cash flow guidance was sharply reset to US$350 million-US$400 million due to inventory builds of approximately US$100 million.
Rising memory costs for cameras and margins on new counter-drone hardware are currently dragging down connected device profitability.
Adjusted EBITDA margin faces near-term pressure from inflationary headwinds, with a larger hit expected in Q4 and extending into 2027-2028.
Earnings reportNew AI featuresProduct launchAI-generated analysis
Axon Enterprise reported strong third-quarter revenue growth of 28% to $909 million, driven by a 43% surge in software and services revenue which reached $437 million. Adjusted EBITDA increased over 33% to $236 million with a margin of 25.9%, reflecting the company's successful transition toward higher-margin recurring revenue streams. However, management removed three delayed federal counter-drone deployments from near-term expectations, totaling approximately $130 million in revenue and $200 million in bookings, citing procurement and installation timing uncertainties.
The company announced a significant strategic investment of $1.2 billion in drone manufacturer Skydio, increasing its ownership stake to 37% and establishing Axon as Skydio's exclusive public safety distributor in the U.S. and Canada. This partnership aims to integrate autonomous flight technology with Axon's existing hardware and software ecosystem for emergency response applications. To fund this investment and build inventory buffers against supply disruptions, Axon reduced its full-year free cash flow outlook to $350 million–$400 million from a previous target of $450 million.
Axon maintains a robust growth trajectory with annual recurring revenue increasing 40% to $1.8 billion and net revenue retention at 126%. Its AI-powered platform solutions grew 106% to $125 million, driven by the Dedrone product line despite the removal of large federal deals from current guidance. While TASER hardware sales softened due to lower demand for the TASER 7 model, management expects the category to return to double-digit growth in the fourth quarter. The company also faces margin headwinds from elevated memory costs expected to persist through 2028.
📈 Q3 revenue surged 28% to $909 million with software hitting 43% growth.
💻 Annual recurring revenue climbed 40% to $1.8 billion at 126% retention.
🤝 Skydio investment reached 37% ownership as exclusive public safety distributor.
⚠️ Removed $130 million in delayed federal counter-drone deployments from near-term view.
📉 Lowered full-year free cash flow outlook to $350M-$400M due to inventory costs.
📈 Axon reported Q3 revenue of $909 million, representing a 28% year-over-year increase.
💻 Software and services revenue jumped 43% to $437 million, approaching half of total revenue.
🤝 Axon invested $1.2 billion in Skydio, raising ownership to 37% and becoming the exclusive public safety distributor.
⚠️ The company removed three delayed federal counter-drone deployments worth $130 million in revenue from near-term expectations.
💰 Adjusted EBITDA rose over 33% to $236 million with a margin of 25.9%.
📉 Axon lowered its full-year free cash flow outlook to $350 million–$400 million due to inventory investment.
🔄 Annual recurring revenue increased 40% to $1.8 billion with net revenue retention at 126%.
🚁 Platform solutions revenue grew 106% to $125 million, primarily driven by the Dedrone product line.
📉 TASER revenue declined modestly to $233 million due to lower sales of the TASER 7 model.
💾 Elevated memory costs are expected to pressure margins through 2027 and 2028.
Bullish Signals
Q3 revenue grew 28% to $909M, showing strong demand.
Software/services revenue surged 43% to $437M.
Secured Skydio partnership with $1.2B investment.
Annual recurring revenue increased 40% to $1.8B.
Adjusted EBITDA grew 33% to $236M.
Risk Factors
Removed $130M revenue and $200M bookings from near-term expectations.
Lowered full-year free cash flow outlook to $350M-$400M.
TASER revenue declined to $233M due to lower TASER 7 sales.
Elevated memory costs expected to pressure margins through 2028.
Bullish Signals
Axon reported Q3 revenue growth of 28% to $909 million, demonstrating strong underlying demand for its public safety technology.
Software and services revenue surged 43% to $437 million, signaling a successful strategic pivot toward higher-margin recurring revenue models.
The company secured a major partnership with Skydio by investing $1.2 billion and becoming the exclusive public safety distributor in North America.
Annual recurring revenue increased 40% to $1.8 billion, while net revenue retention reached 126%, indicating strong customer stickiness.
Platform solutions revenue exploded 106% to $125 million, driven by the Dedrone product line despite the removal of large federal deals from guidance.
Adjusted EBITDA grew over 33% to $236 million with a healthy margin of 25.9%, reflecting improved operational efficiency.
Risk Factors
Management removed three delayed federal counter-drone deployments worth $130 million in revenue and $200 million in bookings from near-term expectations.
Axon lowered its full-year free cash flow outlook to $350 million–$400 million from a prior target of $450 million due to significant inventory investment.
TASER revenue declined modestly to $233 million in the quarter, driven by lower sales of the TASER 7 model.
Elevated memory costs are expected to remain a headwind to margins through 2027 and 2028 unless prices rise materially.
AI integrationAcquisitionCompany updateAI-generated analysis
Axon Enterprise is scheduled to report its third-quarter 2026 earnings results on November 5, following market close. Analysts currently project earnings of $1.90 per share on revenues of $931.1 million, representing a significant year-over-year increase in both metrics. However, the consensus estimate for quarterly earnings has decreased by 2.1% over the past 60 days, while the company's historical track record shows it missed estimates three times in the trailing four quarters with an average negative surprise of 0.8%.
The company expects strong performance from its Connected Devices segment, driven by demand for TASER 10 products and higher cartridge revenues, alongside continued adoption of the Axon Body 4 camera and counter-drone solutions. The Software & Services segment is anticipated to grow due to increased user adoption of premium software and momentum in platforms like Axon Evidence and Axon 911. Revenue estimates for these segments are pegged at $521 million and $417 million respectively, indicating substantial year-over-year growth.
Strategic initiatives, including the February 2026 acquisition of Carbyne to enhance its Axon 911 solution, are expected to boost top-line revenue. Despite these positives, analysts warn that rising operating costs, integration expenses, and stock-based compensation could weigh on the company's bottom line. The stock is trading at a forward P/E ratio of 41.89X, which is notably higher than its industry average and peers like Teledyne Technologies, raising concerns about valuation vulnerability if market sentiment shifts.
Analyst consensus estimates dropped 2.1% in 60 days.
Missed earnings in 3 of last 4 quarters.
Rising costs and comp weigh on upcoming bottom line.
Forward P/E of 41.89X exceeds industry average.
High valuation risks pullbacks if Q3 disappoints.
Bullish Signals
Axon Enterprise is expected to deliver substantial year-over-year revenue growth, with Connected Devices segment revenues pegged at $521 million (28.6% increase) and Software & Services at $417 million (36.7% increase).
The company has successfully integrated Carbyne's cloud-native 911 technology to create Axon 911, expanding its product offerings in the public safety sector.
AXON shares have gained 9.4% over the past six months, significantly outperforming the Zacks Aerospace - Defense Equipment industry which saw a 9.7% decline.
Strong market demand for TASER 10 products and continued adoption of the Axon Body 4 camera are driving solid performance in the Connected Devices segment.
The company maintains a strong presence in the counter-drone space, contributing significantly to segment growth and diversifying its revenue streams.
Risk Factors
The Zacks Consensus Estimate for earnings has decreased 2.1% over the past 60 days, indicating weakening analyst confidence or deteriorating expectations.
Axon Enterprise missed earnings estimates in three of the last four quarters with an average negative surprise of 0.8%, suggesting a history of underperformance relative to consensus.
Rising operating costs, high integration expenses, and stock-based compensation are expected to weigh on the company's bottom line in the upcoming quarter.
The stock is trading at a forward P/E ratio of 41.89X, which is much higher than the industry average of 32.34X and peer Teledyne Technologies' 24.36X, creating valuation risk.
Elevated valuation makes the stock vulnerable to further pullbacks if market sentiment sours or if Q3 results fail to meet high expectations.
Axon Enterprise (NASDAQ:AXON) reported strong financial performance for fiscal year 2025, with revenue reaching approximately $2.8 billion, representing a 33.5% increase from the prior year. The company achieved a net income of roughly $124.9 million, though this resulted in a net margin decline to 4.5% from 18.1% due to significant investments in expanding its product suite and increasing headcount.
The company maintains a robust balance sheet with a debt-to-equity ratio of approximately 0.6x and a current ratio near 2.5x, indicating strong liquidity. However, analysts note that reported free cash flow of $75.1 million is heavily inflated by stock-based compensation, which accounted for roughly 300% of operating cash flow. Axon's business model relies on an integrated ecosystem of hardware and cloud software to lock in long-term contracts with law enforcement agencies.
Looking ahead to fiscal 2026, sales are projected to grow significantly to $3.7 billion, up about a third from the previous year, with net income expected to reach around $290 million and free cash flow anticipated at $425 million. The company faces strategic risks related to dependence on municipal budgets and policy changes, as well as operational challenges in managing sensitive data and semiconductor supply chains.
Despite its strong growth trajectory and positive earnings, Axon trades at a premium valuation compared to peers like Fastly, which some analysts view as more affordable. The stock is priced similarly to tech growth stocks despite being categorized within industrials, creating a potential valuation hurdle for investors seeking entry points.
📈 FY2025 revenue hit $2.8B with 33.5% year-over-year growth.
💰 Net income reached $124.9M while margins fell to 4.5%.
📉 Free cash flow of $75.1M is inflated by 300% stock comp.
🚀 FY2026 sales forecasted at $3.7B with $290M net income.
⚖️ Trades at tech premium despite industrials classification and debt ratio of 0.6x.
📈 Axon Enterprise achieved revenue of approximately $2.8 billion in FY 2025, marking a substantial 33.5% year-over-year growth.
💰 The company reported net income of roughly $124.9 million, though net margins declined to 4.5% due to heavy investment in product expansion and headcount.
📉 Reported free cash flow of $75.1 million is heavily inflated by stock-based compensation, which represented about 300% of operating cash flow.
🚀 Fiscal 2026 sales are forecasted to reach $3.7 billion, representing a one-third increase over the prior year.
💵 Net income for FY 2026 is projected to rise to approximately $290 million with free cash flow expected at $425 million.
⚖️ Axon maintains a healthy balance sheet with a debt-to-equity ratio of 0.6x and a current ratio near 2.5x.
🛡️ The company leverages an integrated ecosystem of hardware and cloud software to secure long-term contracts with law enforcement agencies.
⚠️ Strategic risks include dependence on municipal budgets, policy shifts, and the management of sensitive evidence data.
💹 Axon trades at a significant valuation premium compared to peers like Fastly, priced as a tech growth stock despite its industrials classification.
🌍 Expansion into Europe and Canada is expected to drive future growth alongside new consumer-protection devices.
Bullish Signals
FY2025 revenue hit $2.8B, up 33.5% YoY.
FY2025 net income reached $124.9M despite margin pressure.
FY2026 sales projected to grow ~33% to $3.7B.
FY2026 free cash flow forecasted at $425M.
Strong balance sheet with 0.6x debt-to-equity ratio.
Risk Factors
Net margins fell from 18.1% to 4.5% due to heavy investment.
Free cash flow of $75.1M is inflated by 300% stock comp.
Heavy reliance on law enforcement creates budget and policy risk.
Valuation premium vs peers may be too high for current conditions.
Bullish Signals
Axon Enterprise reported revenue of approximately $2.8 billion in FY 2025, a robust 33.5% increase compared to the prior year.
The company generated net income of roughly $124.9 million in FY 2025, demonstrating its ability to turn profitable despite margin compression.
Fiscal 2026 sales are projected to grow by about a third to $3.7 billion, with net income expected to reach around $290 million.
Free cash flow is forecasted to surge to $425 million in FY 2026, well over the levels seen in 2025.
The company maintains a strong balance sheet with a debt-to-equity ratio of approximately 0.6x and a current ratio near 2.5x.
Risk Factors
Net margins declined from roughly 18.1% in the previous year to around 4.5% as the company invested heavily in expanding its product suite and headcount.
Reported free cash flow of $75.1 million is heavily inflated by stock-based compensation, which represented roughly 300% of operating cash flow.
The company faces strategic dependence on law enforcement agencies globally, making it vulnerable to shifts in municipal budgets and policy changes.
Axon trades at a much higher valuation premium than peers like Fastly, priced as if it were a tech growth stock which may be too high for current conditions.
Axon Enterprise (AXON) is expanding its business beyond traditional body cameras and TASERs into counter-drone systems, a category added at the end of 2024. Despite the stock falling 43.5% over the past year while the S&P 500 gained, historical data shows significant annual gains in nine of ten years from 2016 to 2025. The company's platform solutions revenue more than doubled to $150 million in fiscal Q2 2026, driven largely by its Dedrone counter-drone business, which now accounts for a substantial portion of its total revenue.
Counter-drone demand has evolved from event-specific surges like the World Cup to consistent applications at data centers and corporate campuses. Axon was selected as one of a handful of participants in a $1.5 billion Department of Homeland Security program for counter-drone systems, though the specific capture amount remains unclear. Management indicates that while sales are growing, profitability lags behind peers like Motorola Solutions, with an operating margin of 5.2% in Q2 2026 compared to 25.2% for Motorola.
Financial concerns persist as Axon reported a free cash flow outflow of approximately $56 million in the first half of 2026 due to inventory buildup for meeting demand. The company expects spending to moderate after 2026, but margins are currently weighed down by newer products scaling up and upcoming higher memory costs without tariff refunds. Analysts view the stock as expensive at 171.1 times trailing earnings compared to the S&P 500's 22.6x, highlighting the risk that counter-drone demand or cash flow may fall short of expectations.
Future performance hinges on whether Axon can convert its growing sales into profitable revenue and manage costs effectively as it scales new businesses. The company is expected to report fiscal Q3 2026 earnings in November 2026, which will provide critical insight into whether the anticipated cash flow improvement materializes. Investors are closely watching if the counter-drone segment can sustain growth without eroding margins further or if demand slows post-World Cup.
🚀 Platform solutions revenue surged 123% to $150M driven by counter-drone business.
🛡️ Counter-drone demand expanded to data centers and corporate campuses beyond World Cup.
🏆 Selected for $1.5B DHS program from roughly 60 applicants for counter-drone systems.
💰 Operating margin of 5.2% remains significantly lower than Motorola Solutions' 25.2%.
📉 Free cash flow outflow of $56M in first half due to inventory buildup.
🚀 Axon's platform solutions revenue surged 123% to $150 million in fiscal Q2 2026, primarily driven by its new counter-drone business.
🛡️ Counter-drone demand has expanded beyond the World Cup surge to include data centers and corporate campuses.
🏆 Axon was named a participant in a $1.5 billion DHS program for counter-drone systems, selected from roughly 60 applicants.
💰 Despite revenue growth, Axon's operating margin of 5.2% in Q2 2026 remains significantly lower than Motorola Solutions' 25.2%.
📉 The company reported a free cash flow outflow of $56 million in the first half of 2026 due to inventory buildup for counter-drone demand.
⚠️ Axon trades at 171.1 times trailing earnings, vastly higher than the S&P 500's 22.6x multiple, raising valuation concerns.
📅 Management expects memory costs to increase adjusted EBITDA margins in Q3 2026 before a potential rise in Q4.
🔍 Investors are watching the November 2026 earnings report for confirmation of improved free cash flow and margin stabilization.
Bullish Signals
Platform revenue grew 123% to $150M in Q2 2026.
Risk Factors
Operating margin 5.2% vs Motorola's 25.2% in Q2 2026.
Bullish Signals
Axon's platform solutions revenue grew 123% to $150 million in fiscal Q2 2026, driven by its new counter-drone business.
Counter-drone demand has expanded beyond the World Cup surge to include data centers and corporate campuses.
Axon was selected as one of a handful of participants in a $1.5 billion DHS program for counter-drone systems.
Management stated that counter-drone has quickly become a consistent contributor to results.
Risk Factors
Axon's operating margin of 5.2% in Q2 2026 is significantly lower than Motorola Solutions' 25.2% over the same period.
The company reported a free cash flow outflow of $56 million in the first half of 2026 due to inventory buildup.
Axon trades at 171.1 times trailing earnings, vastly higher than the S&P 500's 22.6x multiple.
Management expects memory costs to increase adjusted EBITDA margins in Q3 2026 before a potential rise in Q4.
Demand could slow after the World Cup, which management called a surge.
Axon could win only a small part of the DHS program, though management said that program is not the only way money will be spent on counter-drones.
Axon Enterprise (AXON) exhibits significantly higher volatility than the broader S&P 500, acting as a risk amplifier rather than a stabilizer for portfolios. Over the year ending October 27, 2026, the stock's annual volatility reached 62.0%, compared to 12.7% for the index. On average market down days, AXON shares fell more than twice as much as the S&P 500, while on up days they gained roughly one and a half times the index advance.
Despite high volatility, Axon has delivered strong growth metrics recently. Sales grew 35% year-over-year in fiscal Q2 2026 (ended June 30, 2026), and operating margins improved to 5.2%, recovering from a loss a year prior. However, management noted that scaling newer businesses, specifically counter-drone systems, is currently taking a hit to these margins.
Over the five-year period ending October 27, 2026, AXON returned 19.5% annually versus 12.5% for the S&P 500, but investors received only about half the return per unit of risk taken compared to the index. The company's thin profits and fast growth trajectory mean that future performance hinges on converting sales expansion into wider profitability, with fiscal Q3 2026 operating margins due in November 2026 being a key metric to watch.
📉 AXON annual volatility hit 62%, double the S&P 500's average.
📈 Fiscal Q2 2026 sales surged 35% year-over-year.
💰 Operating margins improved to 5.2% in fiscal Q2 2026.
📊 Five-year annual return was 19.5%, outpacing the S&P 500.
📅 Watch November 2026 for Q3 2026 margin guidance.
📉 AXON shares demonstrated an annual volatility of 62.0% over the past year, significantly higher than the S&P 500's 12.7%, causing the stock to fall more than twice as far on average market down days.
📈 Sales for Axon grew 35% from a year earlier in fiscal Q2 2026, which ended June 30, 2026, indicating robust top-line expansion despite high market risk.
💰 Operating margins improved to 5.2% in fiscal Q2 2026, up from a small loss a year prior, though management acknowledged margin pressure from scaling counter-drone systems.
📊 Over the five years to October 27, 2026, AXON returned 19.5% annually compared to 12.5% for the S&P 500, but generated only about 0.385 points of return per point of volatility versus 0.735 for the index.
🔍 The stock's correlation with the broader market was loose at 0.32 over the past year, meaning Axon often moves independently of the S&P 500 direction.
📅 Investors are advised to watch fiscal Q3 2026 operating margins due in November 2026 as the critical indicator for whether fast sales growth will translate into wider profits.
Bullish Signals
Sales grew 35% YoY in fiscal Q2 2026.
Operating margin reached 5.2% in fiscal Q2 2026.
Delivered 19.5% annualized return over five years.
Risk Factors
Stock volatility reached 62.0% annually.
Counter-drone scaling hit operating margins.
Five-year risk-adjusted return was half of S&P 500.
Bullish Signals
Axon reported a 35% year-over-year sales growth in fiscal Q2 2026, demonstrating strong demand for its TASER devices and body cameras.
The company successfully turned around its profitability, achieving a 5.2% operating margin in fiscal Q2 2026 after posting a small loss the previous year.
Over the five-year period ending October 27, 2026, AXON delivered an annualized return of 19.5%, outperforming the S&P 500's 12.5% return.
Risk Factors
The stock exhibited extreme volatility with a 62.0% annual reading over the past year, causing it to fall more than twice as far as the S&P 500 on average market down days.
Management stated that scaling newer businesses, specifically counter-drone systems, is currently taking a hit to operating margins.
Over the five-year period, AXON generated only about half the return per unit of risk taken compared to the S&P 500, indicating lower risk-adjusted performance.
TD Cowen has lowered its price target for Axon Enterprise (AXON) from USD 825.00 to USD 800.00, maintaining a Buy rating as of October 26, 2026. This valuation adjustment occurred despite the company reporting robust financial performance in the second quarter of 2026, highlighting a divergence between recent operational results and analyst sentiment regarding future pricing.
During the second quarter ended June 2026, Axon reported revenue of USD 904.39 million, representing a year-over-year increase of 35.30%. The company also posted GAAP net income of USD 29.43 million and diluted earnings per share of USD 0.36. Additionally, Axon raised its full-year 2026 revenue growth guidance to a range of 32% to 34%, up from the previous 30% to 32% outlook.
Management maintained an Adjusted EBITDA margin outlook of 25.50% for the fiscal year. The company is scheduled to release its third-quarter 2026 financial results on November 5, 2026, following the market close, with a webcast set for 5:00 p.m. ET. As of late October 2026, Axon's market capitalization stood at USD 34.6 billion with a price-to-earnings ratio of 176.80.
The contrast between the strong revenue expansion and the analyst target reduction suggests investors are weighing current profitability against future growth sustainability or valuation levels. The upcoming Q3 earnings report will provide critical data to validate the company's ability to sustain its high growth trajectory and margin targets.
📉 TD Cowen cut Axon price target to USD 800 while keeping Buy rating.
💰 GAAP net income reached USD 29.43 million with diluted EPS of USD 0.36.
🚀 Full-year 2026 revenue growth guidance raised to 32%-34%.
📅 Q3 2026 results due November 5, 2026, after market close.
📉 TD Cowen lowered Axon Enterprise's price target from USD 825.00 to USD 800.00 on October 26, 2026, while retaining a Buy rating.
📈 Axon reported second-quarter 2026 revenue of USD 904.39 million, marking a 35.30% year-over-year increase.
💰 The company posted GAAP net income of USD 29.43 million and diluted earnings per share of USD 0.36 for the quarter ended June 2026.
🚀 Axon raised its full-year 2026 revenue growth guidance to 32% to 34%, expanding from a previous range of 30% to 32%.
📊 Management maintained an Adjusted EBITDA margin outlook of 25.50% for the fiscal year 2026.
📅 Axon is scheduled to release third-quarter 2026 financial results on November 5, 2026, after market close.
💵 As of October 27, 2026, Axon's market capitalization was USD 34.6 billion with a P/E ratio of 176.80.
📉 The stock traded at EUR 383.00 on the Lang & Schwarz platform as of October 27, 2026.
🏢 Axon is listed on Nasdaq under the ticker AXON within the Industrials sector.
Bullish Signals
Q2 2026 revenue hit $904.39M, up 35.30% YoY.
Raised full-year 2026 growth guidance to 32%-34%.
Maintained Adjusted EBITDA margin outlook at 25.50%.
Q2 GAAP net income reached $29.43M.
Risk Factors
TD Cowen lowered price target from $825 to $800.
Analysts view current valuation levels as stretched.
Bullish Signals
Axon reported second-quarter 2026 revenue of USD 904.39 million, a significant 35.30% year-over-year increase demonstrating strong top-line growth.
The company raised its full-year 2026 revenue growth guidance to 32% to 34%, indicating management's confidence in sustaining high expansion rates.
Axon maintained an Adjusted EBITDA margin outlook of 25.50%, signaling continued operational efficiency and profitability despite rapid scaling.
The company achieved GAAP net income of USD 29.43 million and diluted earnings per share of USD 0.36 in the second quarter of 2026.
Risk Factors
TD Cowen lowered its price target from USD 825.00 to USD 800.00, suggesting analysts may view current valuation levels as stretched despite strong recent results.
The divergence between robust revenue growth and a lower analyst price target indicates potential concerns regarding future sustainability or margin compression risks.
New AI featuresProduct launchAI-generated analysis
Axon Enterprise unveiled its new Body 5 body camera on October 24 at the IACP 2026 conference in Orlando, marking a significant product launch for the law enforcement technology provider. The device boasts 25 times the AI processing power of previous models and features advanced capabilities like license scanning and multi-tool AI execution. However, Axon has not yet announced a price or specific ship date for the new hardware, which succeeds the Body 4 model introduced in April 2023.
The company's strategic focus remains heavily weighted toward its software ecosystem rather than just hardware sales. In the second quarter, Axon reported that AI Era revenue surged nearly 700% year over year, while total revenue grew by 35%. Software and Services revenue specifically increased by 39.6% to $1.2 billion, significantly outpacing the growth of its Connected Devices segment, which rose 29.1% to $1.58 billion.
Financial analysts note that Axon's hardware lifecycle averages about 2.5 years, yet the Body 4 units have remained in the field for over three years, potentially creating a backlog for upgrades. While Chief Financial Officer Brittany Bagley emphasizes prioritizing AI adoption and usage over immediate pricing, rising memory costs are currently putting pressure on camera margins. The company is expected to report third-quarter results on November 5, with analysts forecasting revenue near $938 million.
Wall Street analysts project Axon's earnings per share to grow approximately 21% annually through 2030, driving potential total returns of around 217% based on current valuation models. The primary risk identified is if AI adoption accelerates faster than the company can monetize it through its software plans, or if hardware upgrade cycles slow down as the installed base ages beyond its typical lifecycle.
📷 Axon launched Body 5 with 25x AI power and license scanning features.
💰 Q2 revenue surged 35% driven by a 700% jump in AI Era software.
⏳ Body 4 units fielded over three years may delay upgrades despite 2.5-year lifecycle.
📈 Analysts forecast ~21% annual EPS growth through 2030 with a $1,330 target.
Axon Enterprise, Inc. (AXON) is highlighted as one of the top defense stock picks within the Goldman Sachs portfolio, ranking 9th among a list of 12 selected companies based on stake value as of December 31, 2024. The firm holds over $180 million in AXON shares, signaling strong institutional interest despite the company's primary focus on law enforcement technology rather than traditional military defense.
The article details Axon's impressive financial trajectory, noting a fiscal 2024 revenue of $2.1 billion, which represents a 33% increase from the prior year and is nearly double the figure from two years ago. The company has achieved twelve consecutive quarters of revenue growth exceeding 25%, with annual net income reaching $377 million and non-GAAP net income at $466 million.
Analyst sentiment remains highly bullish, with a consensus Strong Buy rating and increased hedge fund ownership rising to 64 funds in Q4 2024 from 46 in the previous quarter. Jim Cramer is cited describing Axon's transformation into a dominant software-as-a-service provider for law enforcement, emphasizing its body camera systems as the industry gold standard and its AI capabilities that streamline police reporting.
While Goldman Sachs analysts favor other AI stocks for higher short-term returns, AXON is recognized for its robust financials and expanding software business. The company integrates cloud solutions and hardware to enable modern policing, positioning itself as a key player in the security sector with significant growth momentum.
📈 Goldman Sachs ranks Axon 9th among top 12 defense picks.
💰 Fiscal 2024 revenue hit $2.1 billion, up 33% year-over-year.
🚀 Twelve consecutive quarters of revenue growth exceeded 25%.
🏦 Hedge fund ownership rose to 64 funds in Q4 2024.
⭐ Analysts maintain a consensus Strong Buy rating for the stock.
📈 Axon Enterprise ranks 9th among Goldman Sachs' top 12 defense stock picks based on portfolio stake value.
💰 The company reported $2.1 billion in revenue for fiscal 2024, a 33% year-over-year increase.
🚀 AXON has recorded twelve consecutive quarters of revenue growth exceeding 25%.
📊 Annual net income reached $377 million with non-GAAP net income at $466 million in fiscal 2024.
🏦 Hedge fund ownership increased to 64 funds in Q4 2024, up from 46 in the third quarter.
⭐ Wall Street analysts maintain a consensus Strong Buy rating for the stock.
💻 Jim Cramer praises Axon's transformation into a dominant SaaS provider for law enforcement agencies.
📹 The company's body camera system is described as the gold standard in the industry.
🤖 Axon utilizes AI to reduce administrative drudgery for police officers and improve evidence collection.
💼 Goldman Sachs holds over $180 million in AXON shares within its defense portfolio.
Bullish Signals
Revenue hit $2.1B, up 33% in fiscal 2024.
Bullish Signals
Axon Enterprise reported revenue of $2.1 billion for fiscal 2024, growing 33% from the prior year and nearly doubling the figure from two years ago.
The company has achieved twelve successive quarters of revenue growth at or above 25%, demonstrating consistent expansion.
Annual net income stood at $377 million, supporting a non-GAAP net income of $466 million in fiscal 2024.
Hedge fund ownership increased significantly to 64 funds in Q4 2024, improving from 46 funds at the end of Q3.
Wall Street analysts maintain a consensus Strong Buy rating, reflecting high confidence in the company's prospects.
Goldman Sachs holds over $180 million in AXON shares, ranking it as a top pick in their defense portfolio.
Jim Cramer highlights Axon's evolution into a dominant software-as-a-service system for law enforcement across American cities.
AXON Enterprise (AXON) shares experienced a significant decline of 16.6% between the close on September 22 and October 19, 2026, with the sharpest single-day loss occurring on October 16. Historical analysis indicates that out of 19 prior drops with a full year behind them, 14 resulted in higher stock prices twelve months later, though buyers typically endured further declines before recovery.
Financially, Axon reported $904 million in revenue for fiscal Q2 2026, representing a 35.3% increase from the prior year and marking the tenth consecutive quarter of growth exceeding 30%. Management attributes this surge to device sales driven by products like Dedrone, TASER 10, and Axon Body 4, subsequently raising the midpoint of its fiscal 2026 revenue growth forecast to 33%.
Despite robust top-line expansion, profitability lags significantly behind peers; Axon recorded an operating margin of just 0.7% over the twelve months ending June 30, 2026, compared to 18.5% for the S&P 500. The company also reported negative free cash flow in the first half of fiscal 2026 due to substantial inventory investments aimed at supporting demand and mitigating supply chain risks, particularly regarding rising memory component costs.
Management expects inventory spending to moderate after 2026 and projects approximately $450 million in full-year free cash flow, requiring strong performance in the second half. Investors are currently betting that Axon can successfully convert its rapid sales growth into sustainable profitability once inventory levels stabilize.
📉 AXON shares fell 16.6% recently but historically recovered with median 58% gains.
💰 Q2 revenue surged 35.3% to $904M driven by Dedrone and TASER 10 sales.
📈 Management raised fiscal 2026 growth forecast midpoint to 33%.
⚠️ Operating margin hit 0.7% while free cash flow was negative $56M in Q1-Q2.
💾 Inventory investments rose due to component costs but are expected to moderate later.
📉 AXON shares declined 16.6% between September 22 and October 19, 2026, with a sharp 6.4% drop on October 16.
📈 Historical data shows that 14 out of 19 prior annualized drops left the stock trading higher twelve months later, with a median gain of 58%.
💰 Axon generated $904 million in revenue for fiscal Q2 2026, marking a 35.3% increase from a year earlier.
🚀 Management credited products such as Dedrone, TASER 10, and Axon Body 4 for the rise in device sales.
📊 The company raised the midpoint of its fiscal 2026 revenue growth forecast to 33%, up from 31% in May.
⚠️ Axon recorded an operating margin of 0.7% over the twelve months ending June 30, 2026, compared with 18.5% for the S&P 500.
📉 The stock trades at 9.6 times sales, significantly higher than the 3.1 times multiple for the S&P 500.
🏭 Axon reported negative free cash flow in fiscal Q1 and Q2 2026, resulting in a combined outflow of about $56 million.
📦 Management stated the company is making substantial inventory investments to support customer demand and reduce supply chain risk.
💾 Rising component costs, especially for memory, are cited as a factor impacting cash flow dynamics.
🔮 Axon expects spending on inventory investments to moderate after 2026.
💵 Management projects about $450 million of free cash flow for the full fiscal year 2026.
👀 Investors should watch Axon's free cash flow for fiscal Q3 2026 in the next report.
📊 Over five years to October 2026, VSE stock rose 239% while Axon Enterprise stock rose 107%.
Bullish Signals
Revenue hit $904M in Q2 2026, up 35.3% YoY.
Achieved 10th consecutive quarter of over 30% growth.
Raised fiscal 2026 revenue forecast midpoint to 33%.
Device sales driven by Dedrone, TASER 10, and Body 4.
Trades at 9.6x sales with high profitability potential.
Risk Factors
Operating margin 0.7% vs S&P 500's 18.5%.
Negative free cash flow $56M in Q1-Q2 2026.
Rising memory costs drove negative cash flow.
Buyers faced further falls before best price.
Bullish Signals
Axon generated $904 million in revenue for fiscal Q2 2026, marking a 35.3% increase from a year earlier.
This represents the company's 10th straight quarter of growth above 30%, demonstrating consistent top-line expansion.
Management raised the midpoint of the fiscal 2026 revenue growth forecast to 33%, up from 31% in May.
Device sales are being driven by successful products such as Dedrone, TASER 10, and Axon Body 4.
The stock trades at 9.6 times sales, reflecting a market bet that current growth will eventually convert into higher profitability.
Risk Factors
Profitability has not matched the sales pace, with an operating margin of 0.7% compared to 18.5% for the S&P 500.
The company reported negative free cash flow in both fiscal Q1 and Q2 2026, resulting in a combined outflow of about $56 million.
Management cited rising component costs, especially for memory, as a driver of the negative cash flow situation.
Buyers who entered during previous drops often had to sit through further falls before the stock reached its best price for the year.
Axon Enterprise has secured a significant series of contract awards across U.S. federal agencies, including the Department of Homeland Security and the Department of Veterans Affairs, as well as multiple state corrections departments. These contracts involve the supply of over 22,000 body cameras, digital evidence licenses, TASER 10 devices, counter drone systems, and Skydio drones, indicating a strategic shift from one-off equipment purchases to long-term operational integration within public safety and critical infrastructure plans.
The breadth of these new federal and corrections contracts suggests that Axon's ecosystem is becoming embedded in long-term agency planning rather than serving as temporary procurement. Specifically, four state systems—New York, Ohio, Maryland, and North Carolina—are adopting a comprehensive mix of hardware including Body 4 cameras, TASER 10 devices, Fusus, Dedrone, and Skydio drones within unified environments. This expansion allows Axon's software and services, which generated US$1,400.1m in revenue last year, to deepen as agencies adopt premium, AI-enabled bundles.
Analysts project Axon Enterprise's revenue to reach US$6.9b with earnings of US$445.3m by 2029, based on expectations for 28.8% yearly revenue growth and an earnings increase of approximately US$246m from current levels of US$199.3m. However, the company faces execution risks regarding large deployments and margin pressure from newer categories like counter drone hardware and memory-intensive devices. Additionally, a primary risk remains Axon's reliance on government funding cycles and political priorities, which can shift faster than multi-year plans suggest.
While some bearish analysts worry that tighter regulatory scrutiny on surveillance tools could slow contracts, they still model revenue reaching about US$6.7b by 2029. A key operational risk involves the company's ability to deliver on promised safety metrics, such as reductions in staff assaults or higher force avoidance; failure to hold up these metrics at scale could put follow-on contracts and pricing power under pressure.
📦 Won major federal/state contracts supplying over 22,000 body cameras and TASER devices.
💰 Generated US$1,400.1m software revenue last year with new premium AI bundle adoption.
⚠️ Newer hardware categories expected to weigh on margins and adjusted EBITDA.
⚠️ Faces risks from government funding cycles, regulatory scrutiny, and safety metric delivery.
📦 Axon Enterprise has won major federal and state corrections contracts supplying over 22,000 body cameras, TASER 10 devices, counter drone systems, and Skydio drones.
🏛️ The Department of Homeland Security, Department of Veterans Affairs, and four specific state prison systems (NY, OH, MD, NC) are integrating Axon's ecosystem into long-term operational plans.
💰 Axon's software and services generated US$1,400.1m in revenue last year, with new contracts enabling deeper adoption of premium AI-enabled bundles.
📈 Analysts project Axon Enterprise revenue to reach US$6.9b and earnings of US$445.3m by 2029, implying 28.8% yearly revenue growth.
⚠️ Newer categories like counter drone hardware and memory-intensive devices are expected to weigh on margins and adjusted EBITDA.
🏛️ The company faces significant risk from reliance on government funding cycles and shifting political priorities that may outpace multi-year plans.
📉 Bearish analysts warn that tighter regulatory scrutiny on surveillance tools could slow contract momentum despite modeling US$6.7b revenue by 2029.
⚖️ Failure to deliver on promised safety metrics, such as reduced staff assaults, could pressure follow-on contracts and pricing power.
Bullish Signals
Secured federal/state contracts supplying 22,000+ body cameras and TASER 10 devices.
Risk Factors
Newer categories expected to weigh on margins and adjusted EBITDA.
Reliance on government funding cycles remains a significant risk.
Failed safety metrics could pressure follow-on contracts and pricing power.
Scrutiny on surveillance tools may slow contracts despite $6.7b 2029 revenue model.
Bullish Signals
Axon Enterprise has secured a series of contract awards across U.S. federal agencies and state corrections departments, supplying over 22,000 body cameras, digital evidence licenses, TASER 10 devices, counter drone systems, and Skydio drones.
The breadth of these wins suggests that Axon Enterprise's ecosystem is increasingly being written into long-term operational plans rather than treated as one-off equipment purchases.
Four state systems, including New York, Ohio, Maryland, and North Carolina, are adopting a mix of Body 4, TASER 10, Fusus, Dedrone, and Skydio hardware tied into one environment.
Analysts project Axon Enterprise revenue to reach US$6.9b and earnings of US$445.3m by 2029, based on expectations for 28.8% yearly revenue growth.
The recent federal and corrections wins feed directly into the investment narrative that Axon's public safety ecosystem converts interest in AI tools, cameras, TASER devices, drones, and software into long-term recurring contracts.
Risk Factors
Newer categories like counter drone hardware and memory-intensive devices are expected to weigh on margins and adjusted EBITDA.
The biggest risk remains Axon Enterprise's reliance on government funding cycles and political priorities, which can shift faster than multi-year plans suggest.
If promised safety metrics, such as reductions in staff assaults or higher force avoidance, do not hold up at scale, follow-on contracts and pricing power could come under pressure.
Bearish analysts worry that tighter scrutiny on Axon Enterprise's surveillance tools could slow contracts, even though they still modeled revenue reaching about US$6.7b by 2029.
The article analyzes Axon Enterprise Inc (NASDAQ:AXON) as a potential rebound candidate, highlighting its transition from hardware sales to a software-driven business model centered on the Axon Cloud. In fiscal year 2025, Axon reported revenue of approximately $2.8 billion, a 34% increase driven by cloud adoption and expanded deployments across local and federal agencies. The company achieved a net income of roughly $125 million with a net margin of 4.5%, while maintaining a current ratio of 2.5x and a debt-to-equity ratio of 0.6x.
Axon faces specific risks including high revenue concentration within U.S. law enforcement agencies, dependence on its Taser product line, and significant product liability litigation stemming from use in high-stakes environments. The company also contends with cybersecurity vulnerabilities introduced by its expansion into AI and cloud services, as well as competition from established players like Motorola Solutions and specialized firms such as Wrap Technologies and Byrna Technologies.
Looking ahead to fiscal 2026, analysts project Axon's sales to grow by about one-third to $3.7 billion, with net income reaching $275 million and free cash flow increasing to $447 million. Despite a stock decline of over 20% year-to-date in 2026, the article concludes that Axon is a superior long-term turnaround candidate compared to Turning Point Brands due to the expanding market for security products versus the declining tobacco sector.
📈 FY 2025 revenue surged 34% to $2.8 billion.
☁️ Axon Cloud drives primary growth for public safety.
💰 Net income reached $125 million with 4.5% margin.
🛡️ Strong liquidity with 2.5x current ratio and low debt.
⚠️ Risks include litigation, product concentration, and AI security.
📈 Axon Enterprise reported FY 2025 revenue of approximately $2.8 billion, representing a significant 34% increase over the prior year.
☁️ The company's primary growth engine is now the Axon Cloud, which stores and manages digital evidence for public safety workflows.
💰 Axon achieved a net income of roughly $125 million in FY 2025 with a net margin of approximately 4.5%.
🛡️ As of December 2025, the company maintains a current ratio of nearly 2.5x and a debt-to-equity ratio of approximately 0.6x.
⚠️ Axon faces risks including high revenue concentration within U.S. law enforcement agencies and heavy dependence on its Taser product line.
⚖️ The company is subject to significant product liability and wrongful death litigation risks associated with its products in high-stakes environments.
🔒 Expansion into AI and cloud services introduces cybersecurity vulnerabilities and regulatory uncertainty for Axon Enterprise.
📉 Analysts project fiscal 2026 sales growth of about one-third to $3.7 billion with net income reaching $275 million.
💸 Projected free cash flow for fiscal 2026 is expected to reach $447 million, well above 2025 levels.
📉 Both Axon and Turning Point Brands shares declined by more than 20% year-to-date in 2026.
Bullish Signals
FY 2025 revenue hit $2.8B, up 34% on cloud and hardware.
FY 2025 net income reached $125M with a 4.5% margin.
Axon Cloud is the primary growth engine for digital evidence.
Current ratio stands at 2.5x with debt-to-equity of 0.6x.
FY 2026 sales projected to reach $3.7B with $275M net income.
Risk Factors
Revenue concentrated in U.S. law enforcement and Taser line.
Bullish Signals
Axon Enterprise reported FY 2025 revenue of approximately $2.8 billion, a significant 34% increase driven by cloud adoption and expanded hardware deployments.
The company achieved a net income of roughly $125 million in FY 2025 with a net margin of approximately 4.5% while investing heavily in R&D.
Axon's most significant growth engine is now the Axon Cloud, which stores and manages digital evidence for public and private safety workflows.
As of December 2025, the company maintains a healthy current ratio of nearly 2.5x and a debt-to-equity ratio of approximately 0.6x.
Analysts project fiscal 2026 sales to grow by about one-third to $3.7 billion with net income reaching $275 million.
Projected free cash flow for fiscal 2026 is expected to reach $447 million, significantly exceeding 2025 levels.
The overall market for security products continues to expand, supporting Axon's long-term growth trajectory.
Risk Factors
Axon faces high revenue concentration within U.S. law enforcement agencies and a heavy dependence on its Taser product line.
The company is subject to significant product liability and wrongful death litigation risks stemming from the use of its products in high-stakes environments.
Expansion into AI and cloud services introduces cybersecurity vulnerabilities and regulatory uncertainty for Axon Enterprise.
Axon competes against established players like Motorola Solutions and specialized firms such as Wrap Technologies and Byrna Technologies.
Both Axon and Turning Point Brands shares declined by more than 20% year-to-date in 2026.
Jim Cramer expressed caution regarding Axon Enterprise, Inc. (NASDAQ: AXON) following a caller's inquiry, citing concerns over competition-induced gross margin pressure that he believes makes the stock's current valuation of approximately 54 times earnings unsustainable. While acknowledging CEO Rick Smith and the quality of the product, Cramer noted that competitive dynamics typically erode margins, leading him to pause on the investment despite the company's strong growth trajectory.
Axon reported second-quarter revenue of $904 million, representing a 35% year-over-year increase, marking its tenth consecutive quarter of over 30% growth. Software and services revenue rose 36% to roughly $398 million, with annual recurring revenue reaching $1.6 billion. Management raised its full-year revenue growth outlook to between 32% and 34%, driven by expansions in its unified AI platform, including Axon Assistant and Axon 911, which extend the company's presence beyond body cameras into broader public safety workflows.
Despite strong top-line performance, Axon faced margin headwinds in the second quarter as software and services GAAP gross margins declined to 71.3% from 75.6%. Management attributed this decline to a greater contribution from professional services and the costs associated with scaling newer offerings. However, companywide GAAP gross margin remained stable at 60.4%, offset by stronger connected-device margins. The stock trades at a significant premium compared to competitor Motorola Solutions, leaving less room for error regarding future margin performance or expansion slowdowns.
Institutional sentiment shows signs of cooling, with the number of hedge funds holding Axon dropping from 59 in the preceding quarter to 53 in the second quarter. Broadwood Capital remains the largest institutional holder with 693,504 shares, while short interest stands at 5.32% of the public float. Analysts and investors are closely watching whether the newer services can develop without further pressuring the software margins that currently justify the stock's high valuation multiple.
📈 Axon Q2 revenue surged 35% YoY to $904M with 10 consecutive quarters of >30% growth.
💻 Software revenue jumped 36% to $398M while annual recurring revenue hit $1.6B.
🚀 Management raised full-year growth outlook to 32%-34% driven by new AI tools.
📉 Software gross margins dipped to 71.3% due to scaling costs of new offerings.
⏳ Market watches if new services expand without eroding high-margin software business further.
📉 Jim Cramer paused on Axon due to concerns that competition will drive gross margin pressure, making the current 54x earnings valuation difficult to sustain.
📈 Axon reported Q2 revenue of $904 million, a 35% year-over-year increase, marking its tenth consecutive quarter of over 30% growth.
💻 Software and services revenue grew 36% to roughly $398 million, while annual recurring revenue reached $1.6 billion.
🚀 Management raised the full-year revenue growth outlook to 32%–34%, driven by new AI tools like Axon Assistant and Axon 911.
📉 Q2 software and services GAAP gross margins declined to 71.3% from 75.6% due to professional services mix and scaling costs of new offerings.
⚖️ Companywide GAAP gross margin remained unchanged at 60.4% as stronger connected-device margins offset the software decline.
📉 Hedge fund participation cooled, with holdings dropping from 59 funds in the prior quarter to 53 funds in the second quarter.
📊 Axon trades at approximately 54x forward earnings, significantly higher than competitor Motorola Solutions' 25x multiple.
🔍 Short interest represents 5.32% of the public float, indicating some market skepticism despite strong growth.
⏳ Investors are watching to see if new services can expand without further eroding the high-margin software business.
Bullish Signals
Revenue grew 35% YoY to $904M, tenth consecutive quarter over 30%.
Software revenue up 36%; ARR reached $1.6 billion.
Raised full-year growth outlook to 32%-34%, up from 30%-32%.
Expanded AI platform with Axon Assistant and Axon 911.
Risk Factors
Cramer warns competition threatens margins at unsustainable 54x valuation.
Bullish Signals
Axon reported second-quarter revenue of $904 million, up 35% year-over-year, marking its tenth consecutive quarter of over 30% revenue growth.
Software and services revenue increased 36% to roughly $398 million, while annual recurring revenue reached $1.6 billion.
Management raised its full-year revenue growth outlook to 32%–34%, up from the previous guidance of 30%–32%.
The company expanded its unified AI platform with Axon Assistant and Axon 911, extending its presence beyond body cameras into broader public safety workflows.
Companywide GAAP gross margin remained stable at 60.4% in the second quarter as stronger connected-device margins offset declines in software margins.
Risk Factors
Jim Cramer expressed hesitation on Axon, citing concerns that competition will lead to gross margin pressure which makes the current 54x earnings valuation unsustainable.
Second-quarter software and services GAAP gross margin declined to 71.3% from 75.6%, attributed to a greater contribution from professional services and scaling costs of newer offerings.
Hedge fund participation cooled, with the number of funds holding Axon dropping from 59 in the preceding quarter to 53 in the second quarter.
The stock trades at approximately 54x forward earnings compared to nearly 25x for competitor Motorola Solutions, leaving less room for disappointing margins or slower expansion.
Short interest represented 5.32% of the public float, indicating that a portion of the market remains willing to bet against the shares.
Company updateCustomer contractAI-generated analysis
Axon Enterprise (AXON) has delivered a 133% total return to shareholders over the past five years, though its share price has recently declined. The company's current valuation is being scrutinized against a Discounted Cash Flow (DCF) model which estimates its intrinsic value is broadly in line with the current trading price of approximately $417.
The analysis highlights a new ten-year contract worth roughly $22 million with the City of Lakeland for body cameras, TASER devices, and other public safety tools. This agreement supports the DCF model's assumption that Axon can generate steady, longer-duration cash flows by bundling hardware, software, and services with law enforcement clients.
Simply Wall St narratives suggest the stock could be viewed as 31% undervalued based on its transition from a pure hardware business to an ecosystem of digital evidence and cloud software. However, the article notes that separate research has identified two warning signs investors should weigh before forming a full view on the company's future growth and profitability.
Ultimately, the stock appears fairly priced under current cash flow assumptions, which rely on Axon continuing to scale its platform for police and public safety clients. The valuation implies that the market expects rising cash generation from these bundled contracts over the next decade rather than flat or shrinking free cash flows.
📈 Axon delivered 133% returns to long-term holders over five years.
💰 Latest twelve-month free cash flow reached approximately $136.8 million.
🤝 New $22 million ten-year Lakeland contract supports steadier cash flows.
📊 Current $417 share price aligns with DCF intrinsic value estimates.
⚠️ Separate research flags two warning signs before final valuation.
📈 Axon Enterprise has returned 133% to long-term holders over the past five years despite a recent decline in share price.
💰 The company reported latest twelve-month free cash flow of approximately $136.8 million.
🤝 A new ten-year, roughly $22 million contract with the City of Lakeland supports expectations for steadier cash flows.
📊 Axon's current share price of around $417 appears fairly priced based on a Discounted Cash Flow (DCF) intrinsic value estimate.
🔄 The business is evolving from a hardware provider into an ecosystem built around digital evidence and cloud software.
⚠️ Separate research checks have flagged two warning signs that investors should consider before settling on a valuation.
Bullish Signals
Delivered 133% total return to shareholders over five years.
Risk Factors
Price of $417 implies high expectations with little margin for error.
Research flagged two specific warning signs for investors to consider.
Bullish Signals
Axon Enterprise has delivered a strong 133% total return to shareholders over the past five years.
The company secured a new ten-year, roughly $22 million contract with the City of Lakeland for body cameras and TASER devices.
Axon is successfully transitioning from a hardware business into an ecosystem built around digital evidence and cloud software.
Risk Factors
The current share price of approximately $417 already bakes in expectations for rising cash generation, leaving little room for error.
Separate research checks have identified two specific warning signs that investors should weigh before forming a full view on the company.
Axon Enterprise Inc. reported robust financial performance for the second quarter of 2026, with revenue reaching USD 904.39 million, representing a significant 35.30 percent year-over-year increase. The company's adjusted EBITDA margin stood at 26.80 percent, while GAAP net income was recorded at USD 29.00 million. These figures reflect strong operational execution and growing demand for the company's core products within the security technology sector.
Driven by this momentum, Axon Enterprise issued USD 1.15 billion in zero-coupon convertible notes due in 2031 to bolster its capital structure. The financing deal includes capped call transactions designed to mitigate potential dilution upon conversion, though it introduces a future equity-linked obligation. This strategic move follows the company's decision to lift its full-year 2026 revenue-growth outlook to between 32 percent and 34 percent.
Key growth metrics highlight Axon's expanding market position, with annual recurring revenue surging 39 percent to USD 1.60 billion and future contracted bookings climbing 41 percent to USD 15.10 billion. Despite the high valuation and elevated analyst expectations, the stock traded at EUR 369.50 on October 5, 2026, reflecting investor interest in its growth trajectory while monitoring the implications of the new debt issuance.
Analyst sentiment remains mixed but generally positive, with Goldman Sachs maintaining a Buy rating despite cutting its price target from USD 715 to USD 675. The consensus view among analysts is Moderate Buy, indicating that while the stock's valuation is high relative to its growth rate, investors see potential for continued expansion if Axon can sustain its rapid revenue growth pace.
📈 Q2 2026 revenue surged 35% to USD 904 million driven by security tech demand.
💰 Issued USD 1.15 billion in zero-coupon convertible notes due 2031 for growth funding.
📊 Annual recurring revenue jumped 39% to USD 1.60 billion with strong future bookings.
🚀 Raised full-year 2026 revenue guidance to 32-34%, signaling sustained high growth confidence.
📈 Axon Enterprise reported Q2 2026 revenue of USD 904.39 million, a 35.30 percent year-over-year increase driven by strong demand for its security technology solutions.
💰 The company issued USD 1.15 billion in zero-coupon convertible notes due 2031 to strengthen its balance sheet and fund future growth initiatives.
📊 Annual recurring revenue grew 39 percent to USD 1.60 billion, while future contracted bookings increased 41 percent to USD 15.10 billion in the second quarter.
🚀 Axon lifted its full-year 2026 revenue-growth guidance to a range of 32 percent to 34 percent, signaling confidence in sustaining high growth rates.
📉 Goldman Sachs maintained a Buy rating but cut its price target from USD 715.00 to USD 675.00, reflecting concerns about valuation relative to growth.
🏦 The convertible notes carry no regular interest and have an initial conversion price of USD 652.06 per share, with capped calls intended to reduce dilution.
📈 Adjusted EBITDA reached USD 242.00 million in Q2 2026, resulting in a healthy 26.80 percent margin on the expanded revenue base.
📉 GAAP net income for the quarter was USD 29.00 million, demonstrating profitability despite significant investments and debt issuance.
🌍 Axon's stock traded at EUR 369.50 on October 5, 2026, up 0.56 percent versus the prior close, trading within its 52-week range of USD 339.01 to USD 764.02.
👥 MarketBeat listed a consensus Moderate Buy view from analysts, with 14 Buy ratings and three Hold ratings as of October 1, 2026.
Bullish Signals
Q2 2026 revenue hit USD 904.39M, up 35.30% YoY.
Risk Factors
Goldman cut target from $715 to $675 due to stretched valuation.
Bullish Signals
Axon Enterprise achieved Q2 2026 revenue of USD 904.39 million, a robust 35.30 percent year-over-year increase that validates its market leadership in security technology.
The company successfully issued USD 1.15 billion in convertible notes to secure capital for expansion while maintaining profitability with USD 29.00 million in GAAP net income.
Annual recurring revenue surged 39 percent to USD 1.60 billion, indicating strong customer retention and recurring value from its core products.
Future contracted bookings jumped 41 percent to USD 15.10 billion, demonstrating a robust pipeline of new sales and market share gains.
Axon lifted its full-year 2026 revenue-growth outlook to 32-34 percent, showing management confidence in sustaining high growth despite elevated stock valuation.
Risk Factors
Goldman Sachs cut its price target from USD 715.00 to USD 675.00, suggesting that the current stock valuation may be stretched relative to expected earnings growth.
The issuance of USD 1.15 billion in zero-coupon convertible notes adds a future equity-linked obligation and potential dilution risk if conversion occurs.
Analyst consensus is Moderate Buy rather than Strong Buy, indicating that some investors remain cautious about the company's ability to sustain its rapid growth pace.
Axon Enterprise Inc. reported strong Q2 2026 financial results, generating USD 904.39 million in revenue, a 35.3% year-over-year increase that surpassed the consensus estimate of USD 876.42 million. The company also achieved an adjusted EBITDA of USD 242 million with a margin of 26.8%, while maintaining full-year 2026 revenue growth guidance between 32% and 34%. Despite these operational successes, the stock closed down 2.10% at USD 413.35 on October 2, 2026, reflecting investor caution regarding recent financing activities.
The market reaction was driven primarily by Axon's issuance of USD 1.15 billion in 0% convertible senior notes on September 18, 2026, which included an additional USD 150 million from the underwriters' option. To mitigate potential dilution associated with these notes, Axon utilized a portion of the proceeds to enter into capped call transactions. Analysts and investors are now scrutinizing whether the durability of margins can be maintained alongside this significant capital structure change, particularly given the stock's current price is significantly below its 52-week high.
Wall Street sentiment remains cautiously optimistic with a Moderate Buy consensus from 17 analysts, supported by an average price target of USD 721.57, which represents a potential upside of roughly 74.6% from the October 2 closing price. The company is listed in both the S&P 500 and Nasdaq 100, trading within a 52-week range of USD 339.01 to USD 764.02. Investors will be watching the upcoming earnings report scheduled for November 3, 2026, to assess if revenue growth and margin durability can offset concerns about the new financing terms.
📈 Axon Q2 2026 revenue hit USD 904.39M, up 35.3% YoY.
💰 Company issued USD 1.15B convertible notes on Sept 18, 2026.
🛡️ Axon used USD 114.9M proceeds for capped calls to limit dilution.
📉 Stock dropped 2.10% to USD 413.35 amid financing scrutiny.
🎯 Analysts rate Moderate Buy with USD 721.57 price target.
📈 Axon Enterprise reported Q2 2026 revenue of USD 904.39 million, representing a 35.3% year-over-year increase that beat analyst consensus estimates.
💰 The company issued USD 1.15 billion in 0% convertible senior notes on September 18, 2026, to fund general corporate purposes and growth investments.
🛡️ Axon allocated USD 114.9 million of the note proceeds to capped call transactions specifically designed to reduce potential dilution from the convertible debt.
📉 The stock fell 2.10% to close at USD 413.35 on October 2, 2026, as investors weighed strong operating growth against scrutiny of the new financing structure.
🎯 Analysts maintain a Moderate Buy consensus with an average price target of USD 721.57, implying significant upside potential from current levels.
📅 Axon has provided full-year 2026 revenue growth guidance ranging between 32% and 34%, indicating continued high-growth expectations.
🏢 The company operates within the Industrials sector with a specific focus on Aerospace and Defense, holding membership in both the S&P 500 and Nasdaq 100.
📊 Axon achieved an adjusted EBITDA margin of 26.8% in Q2 2026, demonstrating strong profitability despite the large capital raise.
🔍 MarketBeat lists a Moderate Buy rating from 17 analysts, with 14 Buy ratings and 3 Hold ratings currently active for the stock.
📅 The next scheduled earnings update is set for November 3, 2026, where investors will look for confirmation of margin durability post-financing.
Bullish Signals
Q2 2026 revenue surged 35.3% YoY to $904.39M, beating estimates.
Risk Factors
Stock fell 2.10% amid scrutiny of USD 1.15B convertible notes.
Price at USD 413.35 is far below USD 764.02 high.
Margin durability questioned after substantial capital raised.
Bullish Signals
Axon Enterprise generated USD 904.39 million in Q2 2026 revenue, a robust 35.3% year-over-year increase that exceeded the consensus estimate of USD 876.42 million.
The company achieved an adjusted EBITDA of USD 242 million with a healthy 26.8% margin, confirming strong operational profitability in the quarter.
Axon provided full-year 2026 revenue growth guidance of 32% to 34%, signaling management's confidence in sustaining high-growth trajectories.
Analysts maintain a Moderate Buy consensus with an average price target of USD 721.57, suggesting substantial upside potential from the current trading price.
The company successfully raised USD 1.15 billion via convertible notes while utilizing capped call transactions to actively manage and reduce potential dilution.
Risk Factors
Axon's stock fell 2.10% on October 2, 2026, as investors expressed continued scrutiny regarding the terms of its recent USD 1.15 billion convertible notes issuance.
The company's share price of USD 413.35 is significantly below its 52-week high of USD 764.02, indicating a gap between current valuation and historical peaks.
Investors are concerned about the durability of margins given the substantial capital raised through convertible notes which may alter the company's financial profile.
Axon Enterprise (AXON) shares closed at $413.35, declining 2.1% despite a broader market gain led by the S&P 500 and Nasdaq. Over the past month, the stock has underperformed significantly, dropping 21.54% while lagging its Aerospace sector peers which saw a smaller decline of 6.63%. The company's recent price action contrasts with the wider market uptick, highlighting specific investor concerns or lack of momentum relative to the broader index.
Analysts are closely watching Axon ahead of its upcoming earnings report, with consensus estimates projecting EPS of $1.94 per share and revenue of $935.35 million for the current quarter. These figures would represent substantial year-over-year growth of 65.81% in earnings and 31.62% in revenue compared to the same period last year. Full-year consensus estimates anticipate EPS of $7.88 and revenue of $3.68 billion, indicating a continued trajectory of double-digit growth for both profitability and top-line sales.
Valuation metrics suggest Axon is trading at a premium relative to its industry peers. The company currently commands a Forward P/E ratio of 53.56, which is notably higher than the industry average of 33.53. Additionally, the stock carries a Price-to-Earnings Growth (PEG) ratio of 2.14, slightly above the Aerospace - Defense Equipment industry average of 2.03, reflecting high investor expectations for future performance that may not be fully priced in given the recent stock weakness.
📉 Shares fell 2.1% to $413.35, underperforming major indices.
📉 Stock lost 21.54% this month, lagging sector decline.
🔭 Analysts project EPS of $1.94 and revenue of $935.35M.
💰 Forward P/E ratio stands at 53.56 vs industry average.
🏆 Company ranks in top 16% by Zacks Industry Rank.
📉 Axon Enterprise shares fell 2.1% to close at $413.35, underperforming the S&P 500 and Nasdaq during a market uptick.
📉 The stock has lost 21.54% over the past month, significantly lagging the Aerospace sector's decline of 6.63%.
🔭 Analysts expect Axon to report quarterly earnings of $1.94 per share with revenue reaching $935.35 million.
📈 These projected results would mark a 65.81% year-over-year increase in earnings and a 31.62% rise in revenue.
📅 Full-year consensus estimates call for EPS of $7.88 and revenue of $3.68 billion, representing +15.04% and +32.42% growth respectively.
💰 Axon trades at a Forward P/E ratio of 53.56, which is substantially higher than the industry average of 33.53.
📊 The company holds a PEG ratio of 2.14, slightly above the Aerospace - Defense Equipment industry average of 2.03.
🏆 Axon belongs to an industry ranked in the top 16% of all industries based on Zacks Industry Rank metrics.
Bullish Signals
Analysts project quarterly earnings of $1.94, a 65.81% increase.
Risk Factors
Stock declined 21.54% over past month.
Shares fell 2.1% today despite market gain.
Bullish Signals
Analysts project significant year-over-year growth with expected quarterly earnings of $1.94 per share, representing a 65.81% increase.
Revenue is forecast to reach $935.35 million in the current quarter, marking a 31.62% escalation compared to the year-ago period.
Full-year consensus estimates indicate robust growth with projected earnings of $7.88 per share and revenue of $3.68 billion.
Risk Factors
The stock has declined 21.54% over the past month, significantly underperforming its Aerospace sector peers.
Shares fell 2.1% today despite a broader market gain, indicating specific weakness relative to the S&P 500 and Nasdaq.
Axon Enterprise reported robust second-quarter financial results with revenue reaching USD 904.4 million, representing a significant 35.0 percent year-over-year increase. The company's stock traded at EUR 370.60 on September 30, 2026, reflecting positive market sentiment despite a recent analyst price target adjustment. This strong performance was driven by substantial growth across both its software and services segment, which rose 36.0 percent, and its connected devices division, which increased by 35.0 percent.
Key profitability metrics for the quarter included adjusted EBITDA of USD 242.0 million, yielding a margin of 26.8 percent, while GAAP net income stood at USD 29.0 million. The company demonstrated strong recurring revenue characteristics with annual recurring revenue climbing 39.0 percent to USD 1.6 billion and net revenue retention reaching 126.0 percent. Future contracted bookings increased 41.0 percent to USD 15.1 billion, providing a solid anchor for future growth expectations.
Looking ahead, Axon raised its full-year 2026 revenue-growth outlook to a range of 32.0 percent to 34.0 percent and maintained an adjusted EBITDA margin target of 25.5 percent. While Goldman Sachs lowered its price target from USD 715.00 to USD 675.00 while maintaining a Buy rating, the company's execution against this raised guidance remains a key test for valuation. The firm holds significant cash reserves of USD 685.0 million against USD 1.8 billion in senior notes, positioning it well for continued expansion.
📈 Axon Q2 revenue surged 35% YoY to $904.4 million.
💻 Software and Connected Devices revenues grew 36% and 35%.
🔄 Annual recurring revenue hit $1.6 billion with 126% retention.
📅 Raised 2026 growth outlook to 32-34% range.
📉 Goldman Sachs cut price target to $675, still Buy.
📈 Axon Enterprise reported Q2 revenue of USD 904.4 million, marking a 35.0 percent year-over-year increase.
💻 Software and Services revenue grew 36.0 percent to USD 398.0 million, while Connected Devices revenue rose 35.0 percent to USD 507.0 million.
🔄 Annual recurring revenue climbed 39.0 percent to USD 1.6 billion with net revenue retention at 126.0 percent.
📅 The company raised its 2026 revenue-growth outlook to 32.0-34.0 percent and maintained an adjusted EBITDA margin target of 25.5 percent.
💰 Adjusted EBITDA reached USD 242.0 million for a 26.8 percent margin, with GAAP net income at USD 29.0 million.
📉 Goldman Sachs lowered its price target from USD 715.00 to USD 675.00 while maintaining a Buy rating.
💵 Cash and investments totaled USD 685.0 million against USD 1.8 billion of senior notes as of September 2026.
📅 The next earnings date is scheduled for November 3, 2026, following the quarter ended June 30, 2026.
📊 Stock traded at EUR 370.60 on September 30, 2026, up 0.18 percent from the prior close.
🏢 Market capitalization stands at USD 33.8 billion with a 52-week range between USD 339.01 and USD 764.02.
Bullish Signals
Q2 revenue hit $904.4M, up 35% year over year.
Risk Factors
Goldman Sachs lowered price target to USD 675.00 on Sept 21, 2026.
Q2 operating cash flow of USD 20.0 million is low vs EBITDA.
Bullish Signals
Axon Enterprise achieved Q2 revenue of USD 904.4 million, up 35.0 percent year over year, driven by strong growth in both software/services (USD 398.0 million) and connected devices (USD 507.0 million).
The company demonstrated exceptional recurring revenue strength with annual recurring revenue climbing 39.0 percent to USD 1.6 billion and net revenue retention reaching 126.0 percent.
Future contracted bookings increased 41.0 percent to USD 15.1 billion, indicating a robust pipeline for sustained growth.
Axon raised its full-year 2026 revenue-growth outlook to 32.0-34.0 percent and maintained an adjusted EBITDA margin target of 25.5 percent despite market volatility.
Adjusted EBITDA reached USD 242.0 million with a healthy 26.8 percent margin, significantly outperforming typical industry averages for hardware-focused firms.
Risk Factors
Goldman Sachs lowered its price target from USD 715.00 to USD 675.00 on September 21, 2026, suggesting some analysts view the current valuation as stretched despite strong fundamentals.
Operating cash flow was reported at only USD 20.0 million in Q2, which is notably lower than the adjusted EBITDA of USD 242.0 million and warrants monitoring for working capital efficiency.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)